Stonehouse Jon P — SEC insider filings

SEC reporting owner CIK 1385496. 33 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2020-12-07 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOCRYST PHARMACEUTICALS INC (BCRX)Director231 leg · 30,000 sh · $166,5006 legs · 729,951 sh · $8,928,16154
BELLICUM PHARMACEUTICALS, INC (BLCM)Director8——10
Metsera, Inc. (MTSR)Director2——4

Insider filings — Stonehouse Jon P

FiledFormIssuerReported transactionsSource
2026-09-024BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 644 @ $9.70EDGAR
2026-06-154BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0EDGAR
2026-06-024BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 631 @ $8.91EDGAR
2026-03-034BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 421 @ $8.75 · Option exercise (M): 305,995 @ $3.22 · Disposition to issuer (D): 305,995 @ $8.64 · Option exercise (M): 305,995 (derivative) @ $0EDGAR
2025-12-234BIOCRYST PHARMACEUTICALS INC (BCRX)Tax withholding (F): 61,793 @ $7.41EDGAR
2025-12-194BIOCRYST PHARMACEUTICALS INC (BCRX)Gift (G): 20,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0EDGAR
2025-12-164BIOCRYST PHARMACEUTICALS INC (BCRX)Tax withholding (F): 27,368 @ $7.57EDGAR
2025-11-134Metsera, Inc. (MTSR)Disposition to issuer (D): 2,688 · Grant/award (A): 2,688 (derivative) · Disposition to issuer (D): 47,730 (derivative)EDGAR
2025-04-304Metsera, Inc. (MTSR)Grant/award (A): 47,730 (derivative) @ $19.81EDGAR
2024-12-234BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 362,100 @ $0 · Tax withholding (F): 14,010 @ $7.39 · Gift (G): 20,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Grant/award (A): 750,250 (derivative) @ $0EDGAR
2024-12-174BIOCRYST PHARMACEUTICALS INC (BCRX)Tax withholding (F): 27,525 @ $7.53EDGAR
2024-05-154BIOCRYST PHARMACEUTICALS INC (BCRX)Purchase (P): 30,000 @ $5.55EDGAR
2024-01-044BIOCRYST PHARMACEUTICALS INC (BCRX)Gift (G): 20,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0EDGAR
2023-12-204BIOCRYST PHARMACEUTICALS INC (BCRX)Tax withholding (F): 14,089 @ $6.05EDGAR
2023-12-184BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 127,500 @ $0 · Tax withholding (F): 13,592 @ $6.43 · Grant/award (A): 595,000 (derivative) @ $0EDGAR
2023-06-154BIOCRYST PHARMACEUTICALS INC (BCRX)Gift (G): 25,000 @ $0EDGAR
2023-03-234BIOCRYST PHARMACEUTICALS INC (BCRX)Option exercise (M): 31,055 @ $3.22 · Option exercise (M): 31,055 (derivative) @ $0EDGAR
2023-02-024BIOCRYST PHARMACEUTICALS INC (BCRX)Gift (G): 10,000 @ $0 · Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 · Option exercise (M): 100,000 @ $5.45 · Sale (S): 100,000 @ $10.38 · Option exercise (M): 100,000 (derivative) @ $0EDGAR
2023-01-054BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 121,452 @ $0EDGAR
2023-01-044/ABELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 60,580 @ $0EDGAR
2022-12-214BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 127,500 @ $0 · Grant/award (A): 595,000 (derivative) @ $0EDGAR
2022-12-194BIOCRYST PHARMACEUTICALS INC (BCRX)Sale (S): 14,100 @ $10.90EDGAR
2022-12-024BIOCRYST PHARMACEUTICALS INC (BCRX)Option exercise (M): 214,917 @ $1.42 · Sale (S): 214,917 @ $13 · Option exercise (M): 82,656 @ $1.42 · Sale (S): 82,656 @ $12.80 · Option exercise (M): 214,917 (derivative) @ $0 · Option exercise (M): 82,656 (derivative) @ $0EDGAR
2022-09-024BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 60,580 @ $0EDGAR
2022-09-014/ABELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 21,054 @ $0 · Option exercise (M): 21,054 (derivative) @ $0EDGAR
2022-06-164BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-01-134BIOCRYST PHARMACEUTICALS INC (BCRX)Option exercise (M): 184,000 @ $4.73 · Sale (S): 184,000 @ $15.04 · Option exercise (M): 184,000 (derivative) @ $0EDGAR
2022-01-064BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 21,504 @ $0 · Option exercise (M): 21,504 (derivative) @ $0EDGAR
2021-12-164BIOCRYST PHARMACEUTICALS INC (BCRX)Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 · Grant/award (A): 123,000 @ $0 · Grant/award (A): 574,500 (derivative) @ $0EDGAR
2021-07-074BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 6,500 (derivative) @ $0EDGAR
2021-01-054BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 21,054 (derivative) @ $0EDGAR
2020-12-174BIOCRYST PHARMACEUTICALS INC (BCRX)Option exercise (M): 134,278 @ $4.15 · Sale (S): 134,278 @ $8.32 · Option exercise (M): 134,278 (derivative) @ $0 · Grant/award (A): 870,000 (derivative) @ $0EDGAR
2020-12-074BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 157,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1385496 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs